ASTRAZENECA PLC (AZN)
Clinical trial NCT05952024 updates: 1. completion date: 2027-08-24 → 2029-04-22 2. primary completion date: 2027-08-24 → 2029-04-22
Clinical trial NCT05952024 updates: 1. completion date: 2027-08-24 → 2029-04-22 2. primary completion date: 2027-08-24 → 2029-04-22
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical